A little Background
Lack of medicine takes a toll of 50 million annually. It translates to 100 lives every minute. 9 in 10 top causes of death are associated with diseases in which medicine is hard to get or ineffective. Even more so, we are experiencing these difficulties in the pandemic situation we are in. Failure in data collaboration in the pharma industry globally has been exposed more than ever. Even, the first world countries are helpless after failing to work together to safeguard their citizens. Ultimately, the issue is medicines don't reach people on time and when it does it is expensive. It takes up to a decade or more for new medicines to be available in public distribution. We are in desperate need of a system that helps solve this global health-related issue that has been causing loss of lives.
ClinTex Clinical Trials Intelligence (CTI)
ClinTex Clinical Trials Intelligence (CTI) will help deliver new medicines to patients who are in desperate need. ClinTex is a leading solution provider in pharma and also the team behind CTI. Using analytics, the system evaluates what causes the delay to clinical trials for new medicines. It ensures that medicines reach the people who need them the most. The choice of blockchain as the medium to share information drives collaboration across the industry. Thanks to faster clinical trials, the costs of medicine go down drastically. ClinTex is the pharmaceutical blockchain solution for safer, smarter, and faster delivery of new medicines.
Managing clinical trials with CTI
Clinical trials help test the safety and efficacy of future medicines. ClinTex CTI is a distributed ledger platform that helps writing the end to end decentralized solutions. It uses seven different applications for ensuring the quality of operational improvements. The applications are for operational excellence, clinical data visualizations, predictive analysis, risk based monitoring, patient recruitment and retention, site investigations, and vendor management. It very much reflects the combined expertise of pharma, clinical, data analytics, and software development.
Purpose of CTI
Data analytics and machine learning are put to extensive use in this platform. The front end of CTI is the control panel that helps navigate through the DAPPs. Different types of visual charts and bars are used for quick observation. Data comes from various hospital sites, global health agencies, and other sources. You can constantly monitor every patient's status, especially his/her safety. Besides effectively managing clinical trials, CTI will deliver significant cost savings in the pharma industry. It benefits clinical data managers, project managers, site monitors, and pharmacovigilance staff.
Presale Details
The presale for CTi, official ClinTex tokens is on. Contributions will go towards platform development. You need to complete KYC verification before proceeding with purchases. At a discounted price, you can get each CTi token at $0.05. It counts as a 100% bonus on your investment. $1 million worth of tokens are reserved for presale. Presale ends on the 25th of September or when allocation sells out (whichever is earlier). The total token supply is 200 million CTi tokens, in which 10% goes towards presale. A couple of sale rounds are also taking place at bounce finance which is an easy method to purchase for ethereum users.
Conclusive Comments:
The project has been under development for the last 2-3 years and they are very near to the launch of their apps and services. The project is an extensive one when it comes to medicine, clinical, and healthcare ecosystem, with 7 apps they intend to cover all the aspects of the healthcare system so I think this is a revolutionary project in the healthcare and blockchain sector that will bring massive benefits to the target segments.
Important Links
Website: https://clintex.io//
Medium: https://medium.com/@clintexcti
Telegram: https://t.me/ClinTexCTi
Twitter: https://twitter.com/ClinTexCTi
My forum username: bigcash2011
My Eth wallet: 0x624440fff9763ccbc5ae3e569efc3458c1347b21
Kind Regards!